Trial SWOG-S1914


A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC

Type: Treatment
Phase: Phase III
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Radiation: External
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Jason Ye, M.D.
Other Trial Staff:  Grace Facio, R.N., Marissa Aldana, D.M., Margarita Carranza, D.M., Eduardo Mejia, D.M., America Casillas-Lopez, Coordinator, Apoorva Vishwanath, D.M., Ramy Farag, Coordinator, Brigitte Torres, Coordinator, Sophie Miehl, Coordinator, Sreebharathy Venkatesh, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.